NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

腦積水分流器的全球市場:按類型(心室腹膜,心室心房,心室胸,腰腹膜),年齡組(嬰兒,兒童,成人)進行的市場機會分析和行業預測(2020-2027年)

Hydrocephalus Shunts Market by Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal) and Age Group (Infants, Children, and Adults) - Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 975071
出版日期 內容資訊 英文 181 Pages
商品交期: 2-3個工作天內
價格
腦積水分流器的全球市場:按類型(心室腹膜,心室心房,心室胸,腰腹膜),年齡組(嬰兒,兒童,成人)進行的市場機會分析和行業預測(2020-2027年) Hydrocephalus Shunts Market by Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal) and Age Group (Infants, Children, and Adults) - Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年10月31日內容資訊: 英文 181 Pages
簡介

腦積水是由腦室中腦脊液(CSF)異常積聚引起的神經病。人體每天產生約500毫升的CSF,當吸收後,液體會不斷交換。在正常情況下,產生的液體量與人體吸收速度之間存在微妙的平衡。失去平衡時會發生腦積水。由於心室持續產生CSF,這種破壞會導致體液積聚,從而使心室膨脹並增加腦組織的壓力。通常通過神經外科醫生進行的外科手術來治療這種情況。這涉及在人腦中植入 "分流" 管。該分流器負責將流體從心室引導和轉移到身體的其他部位。在這裡,液體被重新吸收並返回到血液中。外科手術可以控制大多數患者的腦積水,但是分流移植不能治癒這種情況。這是一生的疾病,有一些長期併發症。此外,如果這些併發症未經治療或未得到診斷,可能會導致嚴重的腦損傷並危及生命。

2019年腦積水分流器的全球市場價值為2.91億美元,從2020年到2027年的複合年增長率為2.8%,到2027年將達到3.2201億美元。據預測。全世界腦積水數量的增加是腦積水分流器市場增長的主要驅動力。例如,根據美國國家神經系統疾病和中風研究所的數據,到2020年,全世界將有1,000名嬰兒中的一到兩個患有腦積水。因此,考慮到每年的新生兒總數,將來所有腦積水的患病率有望增加。另外,由於先天性異常和生活方式疾病引起的神經病的增加以及腦和神經損傷的發生率的增加,對腦積水分流術的需求也在增加。此外,先進的可編程瓣膜的使用有助於神經外科醫生在治療過程中從外部調節分流器中使用的瓣膜壓力。預計這將有助於控制與固定壓力閥相關的過排水和排水不足問題,並推動腦積水分流器市場的增長。另外,由於大多數醫療專業人員選擇可編程分流器以減少因反複分流手術而引起的感染和功能障礙,因此在將來將繼續使用可編程閥治療腦積水。預計一年中它將越來越受歡迎。但是,由於現有分流器的感染和故障造成的嚴重損害極大地限制了市場的增長。一些有害的併發症包括不可逆的腦損傷,腦膜炎,心內膜炎,外傷性穿孔,三尖瓣關閉不全,心力衰竭和肺動脈高壓。

另一方面,減少分流併發症的分流技術的進步預計將為市場增長創造有利機會。

本報告調查了全球腦積水分流市場,市場概況,市場規模趨勢以及按類型,年齡組和地區劃分的預測,市場趨勢,增長和限制因素的分析,市場機會,它提供全面的信息,例如競爭條件和主要公司的概況。

目錄

第1章簡介

第2章執行摘要

    • 研究的主要發現
  • CXO的觀點

第3章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資口袋
    • 主要成功策略
  • 波特的五力分析
  • 市場動態
    • 市場因素
      • 腦積水的患病率增加
      • 快速採用高級可編程閥
      • 神經病的發生率增加
    • 抑制因素
      • 與分流功能障礙有關的傳染病
      • 無柄腦積水治療
    • 市場機會
      • 智能分流技術的進步
  • 主要公司的定位
  • 程序信息
    • 北美
    • 歐洲
    • 亞太地區
    • 拉美
  • COVID-19對市場的影響

第4章腦積水市場:按類型

  • 概述
    • 市場規模和預測
  • 心室腹膜(VP)分流
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 房室(VA)分流
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 腹腔胸(VPL)分流
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 腰腹膜(LP)分流器
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家

第5章腦積水市場:按年齡段分組

  • 概述
    • 市場規模和預測
  • 嬰兒
    • 市場規模和預測
    • 市場分析:按國家
  • 兒童
    • 市場規模和預測
    • 市場分析:按國家
  • 成人
    • 市場規模和預測
    • 市場分析:按國家

第6章腦積水市場:按地區

  • 概述
    • 市場規模和預測
  • 北美
    • 主要市場趨勢和機遇
    • 市場規模和預測:按國家
    • 北美腦積水分流市場:按類型
    • 北美腦積水分流市場:按年齡組
    • 美國
      • 美國腦積水分流市場:按類型
      • 美國腦積水分流市場:按年齡段劃分
    • 加拿大
      • 加拿大腦積水分流市場:按類型
      • 加拿大腦積水分流市場:按年齡段劃分
    • 墨西哥
      • 墨西哥腦積水分流市場:按類型
      • 墨西哥腦積水分流市場:按年齡組
  • 歐洲
    • 主要市場趨勢和機遇
    • 市場規模和預測:按國家
    • 歐洲腦積水分流市場:按類型
    • 歐洲腦積水分流市場:按年齡段劃分
    • 德國
      • 德國腦積水分流市場:按類型
      • 德國腦積水分流市場:按年齡組
    • 法國
      • 法國腦積水分流市場:按類型
      • 法國腦積水分流市場:按年齡段劃分
    • 英國
      • 英國腦積水分流市場:按類型
      • 英國腦積水分流市場:按年齡段劃分
    • 意大利
      • 意大利腦積水分流市場:按類型
      • 意大利腦積水分流市場:按年齡段分組
    • 西班牙
      • 西班牙腦積水分流市場:按類型
      • 西班牙腦積水分流市場:按年齡段劃分
    • 其他歐洲
      • 其他歐洲腦積水分流市場:按類型
      • 其他歐洲腦積水分流市場:按年齡組
  • 亞太地區
    • 主要市場趨勢和機遇
    • 市場規模和預測:按國家
    • 亞太地區腦積水分流市場:按類型
    • 亞太地區腦積水分流市場:按年齡段分組
    • 日本
      • 日本腦積水分流市場:按類型
      • 日本腦積水分流市場:按年齡段劃分
    • 中國
      • 中國的腦積水分流市場:按類型
      • 中國的腦積水分流市場:按年齡段劃分
    • 印度
      • 印度腦積水分流市場:按類型
      • 印度腦積水分流市場:按年齡組
    • 澳大利亞
      • 澳大利亞腦積水分流市場:按類型
      • 澳大利亞腦積水分流市場:按年齡段劃分
    • 韓國
      • 韓國腦積水分流市場:按類型
      • 韓國腦積水分流市場:按年齡段劃分
    • 其他亞太地區
      • 其他亞太地區腦積水分流市場:按類型
      • 其他亞太地區腦積水分流市場:按年齡段分組
  • 拉美
    • 主要市場趨勢和機遇
    • 市場規模和預測:按國家
    • LAMEA腦積水市場:按類型
    • LAMEA腦積水市場:按年齡組
    • 巴西
      • 巴西腦積水分流市場:按類型
      • 巴西腦積水分流市場:按年齡段分組
    • 沙特阿拉伯
      • 沙特阿拉伯Hydrohead分流器市場:按類型
      • 沙特阿拉伯的腦積水分流市場:按年齡段劃分
    • 南非
      • 南非腦積水分流市場:按類型
      • 南非腦積水分流市場:按年齡組
    • 其他LAMEA
      • 其他LAMEA腦積水分流器市場:按類型
      • 其他LAMEA腦積水分流市場:按年齡組

第7章公司簡介

  • CHRISTOPH MIETHKE GmbH & CO. KG
  • G. SURGIWEAR LTD.
  • HLL LIFECARE LIMITED
  • HPBIO PROTESES, INC.
  • INTEGRA LIFE SCIENCES
  • KANEKA MEDIX CORPORATION
  • MEDTRONIC PLC
  • NATUS MEDICAL INCORPORATED
  • SPIEGELBERG GmbH & CO. KG
  • TOKIBO CO., LTD
目錄
Product Code: A02349

Hydrocephalus is a neurological disorder caused due to abnormal accumulation of cerebrospinal fluid or CSF in the brain cavities called ventricles. The human body produces approximately 500 ml of CSF on daily basis, with the continuous replacement of the fluid as it is reabsorbed. In normal conditions, there is a subtle balance in between the amount of fluid produced and the rate at which it is absorbed within the body. Hydrocephalus occurs when there is a disruption in this balance. As ventricles produce CSF continuously, this disruption results in the accumulation of fluid, causing ventricles to enlarge and increase pressure on the brain tissues. This condition is commonly treated by surgical procedures, performed by neurosurgeons, which involves implanting a tube "shunt" into the human brain. This shunt is responsible for channeling and diverting the fluid from ventricles to other parts of the body, wherein it can be reabsorbed and transported back to the bloodstream. Surgical procedure controls hydrocephalus in most patients, however, implanting a shunt does not cure the condition. It is a life-long disorder, accompanied by several long-term complications. Moreover, if these complications are left untreated or undiagnosed, they cause severe brain damages and could be life-threatening.

The global hydrocephalus shunts market was valued at $291.00 million in 2019 and is projected to reach $322.01 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Growth in the number of hydrocephalic patients across the world majorly drives the growth of the hydrocephalus shunts market. For instance, according to the National Institute of Neurological Disorders and Stroke, in 2020, 1 to 2 of every 1000 babies are born with hydrocephalus, globally. Thus, considering the total number of newborns per year, the prevalence of hydrocephalus is all set to increase in the future. Furthermore, a rise in cases of neurological disorders, owing to congenital abnormalities and lifestyle diseases as well as a rise in incidences of brain and nerve injuries, boosts the demand for hydrocephalic shunts. In addition, the use of advanced programmable valves helps neurosurgeons to externally adjust valve pressure used in shunts during the treatment. This thereby helps in controlling over-draining and under-draining issues associated with fixed pressure valves, which, in turn, is expected to drive the growth of the hydrocephalic shunts market. In addition, the use of programmable valves in treating hydrocephalus is anticipated to gain popularity in the coming years as most the medical professionals are opting for programmable shunts to reduce infections and malfunctions caused due to repetitive shunt surgeries. However, serious damages caused by infections and malfunctions of existing shunts greatly limit market growth. Some deleterious complications include irreversible brain injuries, meningitis, endocarditis, traumatic perforation, tricuspid regurgitation, heart failure, pulmonary hypertension, and others.

On the contrary, advancements in shunt technology for reducing shunt complications are projected to create lucrative opportunities for market growth.

The global hydrocephalus shunts market is segmented on the basis of type, age group, and region. By type, the market is classified into ventriculo-peritoneal shunts, ventriculo-atrial shunts, ventriculo-pleural shunts, and lumbo-peritoneal shunts. By age group, the hydrocephalus shunts market is categorized into infants, children, and adults. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global hydrocephalus shunt market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

  • By Type
  • Ventriculo-peritoneal
  • Ventriculo-atrial
  • Ventriculo-pleural
  • Lumbo-peritoneal
  • By Age Group
  • Infants
  • Children
  • Adults
  • By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Christoph Miethke GmbH & Co. KG
  • G. Surgiwear Ltd.
  • HLL Lifecare Limited
  • HpBio Proteses, Inc.
  • Integra Life Sciences
  • Kaneka Medix Corporation
  • Medtronic plc
  • Natus Medical Incorporated
  • Spiegelberg GmbH & CO. KG
  • Tokibo Co., Ltd.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Growth in prevalence of hydrocephalus
      • 3.4.1.2.Surge in adoption of advanced programmable valves
      • 3.4.1.3.Increase in incidences of neurological disorders
    • 3.4.2.Restraints
      • 3.4.2.1.Shunt malfunction and related infections
      • 3.4.2.2.Shunt-free treatments for hydrocephalus
    • 3.4.3.Opportunity
      • 3.4.3.1.Advancements in smart shunt technology
  • 3.5.Top player positioning
  • 3.6.Procedural Information
    • 3.6.1.North America
    • 3.6.2.Europe
    • 3.6.3.Asia-Pacific
    • 3.6.4.LAMEA
  • 3.7.COVID-19 Impact on the market

CHAPTER 4:HYDROCEPHALUS SHUNT MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Ventriculo-peritoneal (VP) shunts
    • 4.2.1.Key market trends and growth opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
  • 4.3.Ventriculo-atrial (VA) shunts
    • 4.3.1.Key market trends and growth opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country
  • 4.4.Ventriculo-pleural (VPL) shunts
    • 4.4.1.Key market trends and growth opportunities
    • 4.4.2.Market size and forecast
    • 4.4.3.Market analysis, by country
  • 4.5.Lumbo-peritoneal (LP) shunts
    • 4.5.1.Key market trends and growth opportunities
    • 4.5.2.Market size and forecast
    • 4.5.3.Market analysis, by country

CHAPTER 5:HYDROCEPHALUS SHUNT MARKET, BY AGE GROUP

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Infants
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Children
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Adults
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country

CHAPTER 6:HYDROCEPHALUS SHUNTS MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key market trends and opportunities
    • 6.2.2.Market size and forecast, by country
    • 6.2.3.North America hydrocephalus shunts market, by type
    • 6.2.4.North America hydrocephalus shunts market, by age group
    • 6.2.5.U.S.
      • 6.2.5.1.U.S. hydrocephalus shunts market, by type
      • 6.2.5.2.U.S. hydrocephalus shunts market, by age group
    • 6.2.6.Canada
      • 6.2.6.1.Canada hydrocephalus shunts market, by type
      • 6.2.6.2.Canada hydrocephalus shunts market, by age group
    • 6.2.7.Mexico
      • 6.2.7.1.Mexico hydrocephalus shunts market, by type
      • 6.2.7.2.Mexico hydrocephalus shunts market, by age group
  • 6.3.Europe
    • 6.3.1.Key market trends and opportunities
    • 6.3.2.Market size and forecast, by country
    • 6.3.3.Europe hydrocephalus shunts market, by type
    • 6.3.4.Europe hydrocephalus shunts market, by age group
    • 6.3.5.Germany
      • 6.3.5.1.Germany hydrocephalus shunts market, by type
      • 6.3.5.2.Germany hydrocephalus shunts market, by age group
    • 6.3.6.France
      • 6.3.6.1.France hydrocephalus shunts market, by type
      • 6.3.6.2.France hydrocephalus shunts market, by age group
    • 6.3.7.UK
      • 6.3.7.1.UK hydrocephalus shunts market, by type
      • 6.3.7.2.UK hydrocephalus shunts market, by age group
    • 6.3.8.Italy
      • 6.3.8.1.Italy hydrocephalus shunts market, by type
      • 6.3.8.2.Italy hydrocephalus shunts market, by age group
    • 6.3.9.Spain
      • 6.3.9.1.Spain hydrocephalus shunts market, by type
      • 6.3.9.2.Spain hydrocephalus shunts market, by age group
    • 6.3.10.Rest of Europe
      • 6.3.10.1.Rest of Europe hydrocephalus shunts market, by type
      • 6.3.10.2.Rest of Europe hydrocephalus shunts market, by age group
  • 6.4.Asia-Pacific
    • 6.4.1.Key market trends and opportunities
    • 6.4.2.Market size and forecast, by country
    • 6.4.3.Asia-Pacific hydrocephalus shunts market, by type
    • 6.4.4.Asia-Pacific hydrocephalus shunts market, by age group
    • 6.4.5.Japan
      • 6.4.5.1.Japan hydrocephalus shunts market, by type
      • 6.4.5.2.Japan hydrocephalus shunts market, by age group
    • 6.4.6.China
      • 6.4.6.1.China hydrocephalus shunts market, by type
      • 6.4.6.2.China hydrocephalus shunts market, by age group
    • 6.4.7.India
      • 6.4.7.1.India hydrocephalus shunts market, by type
      • 6.4.7.2.India hydrocephalus shunts market, by age group
    • 6.4.8.Australia
      • 6.4.8.1.Australia hydrocephalus shunts market, by type
      • 6.4.8.2.Australia hydrocephalus shunts market, by age group
    • 6.4.9.South Korea
      • 6.4.9.1.South Korea hydrocephalus shunts market, by type
      • 6.4.9.2.South Korea hydrocephalus shunts market, by age group
    • 6.4.10.Rest of Asia-Pacific
      • 6.4.10.1.Rest of Asia-Pacific hydrocephalus shunts market, by type
      • 6.4.10.2.Rest of Asia-Pacific hydrocephalus shunts market, by age group
  • 6.5.LAMEA
    • 6.5.1.Key market trends and opportunities
    • 6.5.2.Market size and forecast, by country
    • 6.5.3.LAMEA hydrocephalus shunts market, by type
    • 6.5.4.LAMEA hydrocephalus shunts market, by age group
    • 6.5.5.Brazil
      • 6.5.5.1.Brazil hydrocephalus shunts market, by type
      • 6.5.5.2.Brazil hydrocephalus shunts market, by age group
    • 6.5.6.Saudi Arabia
      • 6.5.6.1.Saudi Arabia hydrocephalus shunts market, by type
      • 6.5.6.2.Saudi Arabia hydrocephalus shunts market, by age group
    • 6.5.7.South Africa
      • 6.5.7.1.South Africa hydrocephalus shunts market, by type
      • 6.5.7.2.South Africa hydrocephalus shunts market, by age group
    • 6.5.8.Rest of LAMEA
      • 6.5.8.1.Rest of LAMEA hydrocephalus shunts market, by type
      • 6.5.8.2.Rest of LAMEA hydrocephalus shunts market, by age group

CHAPTER 7:COMPANY PROFILES

  • 7.1.CHRISTOPH MIETHKE GmbH & CO. KG
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Business performance
    • 7.1.5.Key strategic moves and developments
  • 7.2.G. SURGIWEAR LTD.
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Business performance
  • 7.3.HLL LIFECARE LIMITED
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Business performance
  • 7.4.HPBIO PROTESES, INC.
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Business performance
  • 7.5.INTEGRA LIFE SCIENCES
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.3.Operating business segments
    • 7.5.4.Business performance
    • 7.5.5.Key strategic moves and developments
  • 7.6.KANEKA MEDIX CORPORATION
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Business performance
  • 7.7.MEDTRONIC PLC
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Business performance
  • 7.8.NATUS MEDICAL INCORPORATED
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segments
    • 7.8.4.Business performance
    • 7.8.5.Key strategic moves and developments
  • 7.9.SPIEGELBERG GmbH & CO. KG
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Business performance
  • 7.10.TOKIBO CO., LTD
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Business performance

LIST OF TABLES

  • TABLE 01.HYDROCEPHALUS SHUNT PROCEDURES, 2019-2027 ($MILLION)
  • TABLE 02.HYDROCEPHALUS SHUNT PROCEDURES, 2019-2027 ($MILLION)
  • TABLE 03.HYDROCEPHALUS SHUNT PROCEDURES, 2019-2027 ($MILLION)
  • TABLE 04.HYDROCEPHALUS SHUNT PROCEDURES, 2019-2027 ($MILLION)
  • TABLE 05.HYDROCEPHALUS SHUNT PROCEDURES, 2019-2027 ($MILLION)
  • TABLE 06.HYDROCEPHALUS SHUNT: OVERVIEW
  • TABLE 07.HYDROCEPHALUS SHUNT MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 08.HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-PERITONEAL (VP) TYPE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-ATRIAL (VA) TYPE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-PLEURAL (VPL) TYPE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.HYDROCEPHALUS SHUNT MARKET FOR LUMBO-PERITONEAL (LP) TYPE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.HYDROCEPHALUS SHUNT MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 13.HYDROCEPHALUS SHUNT MARKET FOR INFANT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.HYDROCEPHALUS SHUNT MARKET FOR CHILDREN, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.HYDROCEPHALUS SHUNT MARKET FOR ADULT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.HYDROCEPHALUS SHUNTS MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.NORTH AMERICA HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 18.NORTH AMERICA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 19.NORTH AMERICA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 20.U.S. HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 21.U.S. HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 22.CANADA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 23.CANADA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 24.MEXICO HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 25.MEXICO HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 26.EUROPE HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 27.EUROPE HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 28.EUROPE HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 29.GERMANY HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 30.GERMANY HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 31.FRANCE HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 32.FRANCE HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 33.UK HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 34.UK HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 35.ITALY HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 36.ITALY HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 37.SPAIN HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 38.SPAIN HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 39.REST OF EUROPE HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 40.REST OF EUROPE HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 41.ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 42.ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 43.ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 44.JAPAN HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 45.JAPAN HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 46.CHINA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 47.CHINA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 48.INDIA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 49.INDIA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 50.AUSTRALIA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 51.AUSTRALIA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 52.SOUTH KOREA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 53.SOUTH KOREA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 54.REST OF ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 55.REST OF ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 56.LAMEA HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 57.LAMEA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 58.LAMEA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 59.BRAZIL HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 60.BRAZIL HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 61.SAUDI ARABIA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 62.SAUDI ARABIA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 63.SOUTH AFRICA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 64.SOUTH AFRICA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 65.REST OF LAMEA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 66.REST OF LAMEA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
  • TABLE 67.MIETHKE: COMPANY SNAPSHOT
  • TABLE 68.MIETHKE: OPERATING SEGMENTS
  • TABLE 69.G. SURGIWEAR: COMPANY SNAPSHOT
  • TABLE 70.G. SURGIWEAR: OPERATING SEGMENTS
  • TABLE 71.HLL LIFECARE LIMITED: COMPANY SNAPSHOT
  • TABLE 72.HLL LIFECARE LIMITED: OPERATING SEGMENTS
  • TABLE 73.HPBIO PROTESES, INC.: COMPANY SNAPSHOT
  • TABLE 74.HPBIO PROTESES, INC.: OPERATING SEGMENTS
  • TABLE 75.INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT
  • TABLE 76.INTEGRA LIFE SCIENCES: OPERATING SEGMENTS
  • TABLE 77.KANEKA: COMPANY SNAPSHOT
  • TABLE 78.KANEKA: OPERATING SEGMENTS
  • TABLE 79.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 80.MEDTRONIC: OPERATING SEGMENTS
  • TABLE 81.NATUS MEDICAL: COMPANY SNAPSHOT
  • TABLE 82.NATUS MEDICAL: OPERATING SEGMENTS
  • TABLE 83.SPIEGELBERG: COMPANY SNAPSHOT
  • TABLE 84.SPIEGELBERG: OPERATING SEGMENTS
  • TABLE 85.TOKIBO: COMPANY SNAPSHOT
  • TABLE 86.G. SURGIWEAR: OPERATING SEGMENTS

LIST OF FIGURES

  • FIGURE 01.HYDROCEPHALUS SHUNTS MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2020*
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2017-2020* (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020*
  • FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.LOW THREAT OF NEW ENTRANTS
  • FIGURE 09.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 10.HIGH COMPETITIVE REIVALRY
  • FIGURE 11.DRIVERS, RESTRAINTS, AND OPPORTUNITY
  • FIGURE 12.PREVALENCE OF HYDROCEPHALUS PER 10,000 BIRTHS, 2011 TO 2018, EUROPE, BY COUNTRY
  • FIGURE 13.TOP PLAYER POSITIONING, 2019
  • FIGURE 14.COMPARATIVE ANALYSIS OF HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-PERITONEAL (VP) TYPE, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-ATRIAL (VA) TYPE, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 16.COMPARATIVE ANALYSIS OF HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-PLEURAL (VPL) TYPE, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF HYDROCEPHALUS SHUNT MARKET FOR LUMBO-PERITONEAL (LP) TYPE, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF HYDROCEPHALUS SHUNT MARKET FOR INFANT, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF HYDROCEPHALUS SHUNT MARKET FOR CHILDREN, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF HYDROCEPHALUS SHUNT MARKET FOR ADULT, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 21.HLL: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 22.HLL: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 23.HLL: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 24.INTEGRA LIFE SCIENCES: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 25.INTEGRA LIFE SCIENCES: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 26.INTEGRA LIFE SCIENCES: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 27.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 28.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 29.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 30.NATUS MEDICAL: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 31.NATUS MEDICAL: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 32.NATUS MEDICAL: REVENUE SHARE, BY REGION, 2019 (%)